fzorrilla@zorcapital.com @Zortrades
#STOCKS
Tuesday, September 8, 2015
Why You Should Consider Investing In Biotechs and Why You Don't
Akebia Therapeutics up 70% in the after hours is why you should consider buying biotechs and Tetraphase Pharmaceuticals down 79% is why many don't. Small-cap biotechs offer the biggest mispricing (opportunities) in the market; a promised land full of landmines. A basket of biotechs and or the ETF's (XBI, BBH) make more sense to me than a flyer with one.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment